Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Borg

Showing results (121-130 of 224) with videos related to

Pageof 23
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 14, 2015
Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinomaMarine Jary, Dewi Vernerey, Thierry Lecomte, et al.
Cancer Research|April 9, 2009
Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patientsCédric Ménard, Jean-Yves Blay, Christophe Borg, et al.
Cancers|December 9, 2020
EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung CarcinomasCamille Lachat, Diane Bruyère, Amandine Etcheverry, et al.
Oncoimmunology|November 17, 2022
Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapyAngélique Vienot, Jean-René Pallandre, Elodie Renaude, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2022
Impact of trough concentrations of regorafenib and its major metabolites M-2 and M-5 on overall survival of chemorefractory metastatic colorectal cancer patients: Results from a multicentre GERCOR TEXCAN phase II studyBenoit Rousseau, Arezki K Boukerma, Julie Henriques, et al.
Journal for Immunotherapy of Cancer|May 19, 2025
Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL studyLeonard Depotte, Paula Nay, Christophe Borg, et al.
International Journal of Cancer|July 30, 2016
Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological scoreMarine Jary, Thierry Lecomte, Olivier Bouché, et al.
Journal for Immunotherapy of Cancer|November 5, 2020
RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II studyRomain Cohen, Jaafar Bennouna, Aurélia Meurisse, et al.
Oncoimmunology|February 16, 2017
Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancerLaetitia Fend, Sylvie Rusakiewicz, Julien Adam, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 16, 2023
Evaluation of immune infiltrate according to the HER2 status in colorectal cancerChloé Molimard, Fanny Dor, Alexis Overs, et al.
Pageof 23

Showing results (121-130 of 224) with videos related to

Sort By:
Pageof 23
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 14, 2015
Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinomaMarine Jary, Dewi Vernerey, Thierry Lecomte, et al.
Cancer Research|April 9, 2009
Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patientsCédric Ménard, Jean-Yves Blay, Christophe Borg, et al.
Cancers|December 9, 2020
EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung CarcinomasCamille Lachat, Diane Bruyère, Amandine Etcheverry, et al.
Oncoimmunology|November 17, 2022
Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapyAngélique Vienot, Jean-René Pallandre, Elodie Renaude, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2022
Impact of trough concentrations of regorafenib and its major metabolites M-2 and M-5 on overall survival of chemorefractory metastatic colorectal cancer patients: Results from a multicentre GERCOR TEXCAN phase II studyBenoit Rousseau, Arezki K Boukerma, Julie Henriques, et al.
Journal for Immunotherapy of Cancer|May 19, 2025
Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL studyLeonard Depotte, Paula Nay, Christophe Borg, et al.
International Journal of Cancer|July 30, 2016
Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological scoreMarine Jary, Thierry Lecomte, Olivier Bouché, et al.
Journal for Immunotherapy of Cancer|November 5, 2020
RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II studyRomain Cohen, Jaafar Bennouna, Aurélia Meurisse, et al.
Oncoimmunology|February 16, 2017
Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancerLaetitia Fend, Sylvie Rusakiewicz, Julien Adam, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 16, 2023
Evaluation of immune infiltrate according to the HER2 status in colorectal cancerChloé Molimard, Fanny Dor, Alexis Overs, et al.
Pageof 23